|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 31/18 |
| (11) | Patento numeris | 2934589 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13866337.2 |
| Europos patento paraiškos padavimo data | 2013-12-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/076051 |
| Data | 2013-12-18 |
| (87) | Numeris | WO 2014/100139 |
| Data | 2014-06-26 |
| (30) | Numeris | Data | Šalis |
| 201261738777 P | 2012-12-18 | US | |
| 201361864942 P | 2013-08-12 | US |
| (72) |
SONG, Ruijiang, US
HO, David, D., US
|
| (73) |
The Rockefeller University,
1230 York Avenue, New York, NY 10065,
US
|
| (54) | GLYCAN-MODIFIED ANTI-CD4 ANTIBODIES FOR HIV PREVENTION AND THERAPY |
| GLYCAN-MODIFIED ANTI-CD4 ANTIBODIES FOR HIV PREVENTION AND THERAPY |